Substitutes and alternatives to platelet transfusions in thrombocytopenic patients

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 7, 2003, Pages 1637-1641

  Blajchman, M A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Blood products; Platelet substitutes; Platelet transfusions; Thrombocytopenia

Indexed keywords

BLOOD SUBSTITUTE;

BLOOD STORAGE; FREEZE DRYING; HUMAN; PHYSIOLOGY; REVIEW; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD SUBSTITUTES; FREEZE DRYING; HUMANS; PLATELET COUNT; PLATELET TRANSFUSION; THROMBOCYTOPENIA;

EID: 0141609782     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00332.x     Document Type: Review

References (31)

1. Lee DH, Blajchman MA. Novel treatment modalities: New platelet preparations and substitutes. Br J Haematol 2001; 114: 496-505.
2. Blajchman MA. Substitutes for success. Nature Med 1999; 5: 17-8.
3. Lee DH, Blajchman MA. Novel platelet products and substitutes. Transf Med Rev 1998; 12: 175-87.
4. Alving BM, Reid TJ, Fratantoni JC, Finlayson JS. Frozen platelets and platelet substitutes in transfusion medicine. Transfusion 1997; 37: 866-76.
5. Reid TJ, Gao D. Symposium on cryopreservation of human platelets: An overview. Cryobiology 1999; 38: 177-9.
6. Currie LM, Lichtiger B, Livesey SA, Tansey W, Yang DJ, Connor J. Enhanced circulatory parameters of human platelets cryopreserved with second-messenger effectors: An in vivo study of 16 volunteer platelet donors. Br J Haematol 1999; 105: 826-31.
7. Vostal JG, Mondoro TH. Liquid cold storage of platelets: a revitalized possible alternative for limiting bacterial contamination of platelet products. Transfus Med Rev 1997; 11: 286-95.
8. Hoffmeister KM, Felbinger TW, Falet H, Denis CV, Bergmeier W, Mayadas TN, von Andrian UH, Wagner DD, Stossel TP, Hartwig JH. The clearance mechanism of chilled blood platelets. Cell 2003; 112: 87-97.
9. Hoffmeister KM, Falet H, Toker A, Barkalow K, Stossel T, Hartwig JH. Mechanisms of cold-induced platelet actin assembly. J Biol Chem 2001; 276: 24751-9.
10. Wolkers WF, Walker NJ, Tablin F, Crowe JH. Human platelets loaded with trehalose survive freeze-drying. Cryobiology 2001; 42: 79-87.
11. Blajchman MA. Incidence and significance of the bacterial contamination of blood components. Dev Biol Stand 2002; 108: 59-67.
12. Corash L. Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates: Current research perspectives. Transf Med Rev 1999; 13: 18-30.
13. Goodrich RP. The use of riboflavin for the inactivation of pathogens in blood products. Vox Sang 2000; 78 (Suppl. 2): 211-5.
14. van Rhenen D, Gulliksson H, Cazenave JP, Pamphilon D, Ljungman P, Kluter H, Vermeij H, Kappers-Klunne M, de Greef G, Laforet M, Lioure B, Davis K, Marblie S, Mayaudon V, Flament J, Conlan M, Lin L, Metzel P, Buchholz D, Corash L; euroSPRITE trial. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 2003; 101: 2426-33.
15. McCullough J, Vesole D, Benjamin RJ, Slichter S, Pineda A, Snyder E, Stadtmauer E, Lopez-Plaza I, Coutre S, Strauss RG, Goodnough LT, Firdey J, Raife T, Cable R, Murphy S, Howard F, Davis K, Koutsoukos A, Lin L, Metzel P, Buchholz DH, Corash L, Conlan MG. Pathogen inactivated platelets using Helinx™ technology are hemostatically effectve in thrombocytopenic patients. The SPRINT Trial. Blood 2001; 98 (Suppl.): 405a [Abstract].
16. Kluter H, Chapuis B, Cazenave J-P, Hastka J, Beris P, Dufour P, Janetzko K, Flament J, Marblie S, Mayaudon V, Lin L, Conlan M. Apheresis platelets treated with the INTERCEPT blood system for pathogen inactivation provide platelet count increments and hemostasis comparable to conventional platelets. Vox Sanguinis 2002; 83 (Suppl. 2): 110 [Abstract].
17. Read MS, Reddick RL, Bode AP, Bellinger DA, Nichols TC, Taylor K, Smith SV, McMahon DK, Griggs TR, Bringhous KM. Preservation of hemostatic and structural properties of rehydrated lyophilised platelets: Potential for long-term storage of dried platelets for transfusion. Proc Natl Acad Sci USA 1995; 92: 397-401.
18. Bode AP, Read MS, Reddick RL. Activation and adherence of lyophilised human platelets on canine vessel strips in the Baumgartner perfusion chamber. J Lab Clin Med 1999; 133: 200-11.
19. Chao FC, Kim BK, Houranieh AM, Liang FH, Konrad MW, Swisher SN, Tullis JL. Infusible platelet membrane microvesicles: A potential transfusion substitute for platelets. Transfusion 1996; 36: 536-42.
20. Levi M, Friederich PW, Middleton S, de Groot PG, Wu YP, Harris R, Biemond BJ, Heijnen HF, Levin J, ten Cate JW. Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits. Nature Med 1999; 5: 107-11.
21. Yen RCK, Ho TWC, Blajchman MA. A new hemostatic agent. Thrombospheres shorten the bleeding time in thrombocytopenic rabbits. Thromb Haemost 1995; 73 (Suppl.): 986 [Abstract].
22. Yen RCK, Ho TWC, Blajchman MA. A novel approach to correcting the bleeding associated with thrombocytopenia. Transfusion 1995; 35 (Suppl.): 41S [Abstract].
23. Novotny VMJ, Doxiadis IIN, Brand A. The reduction of HLA class I expression on platelets: a potential approach in the management of HLA-alloimmunized refractory patients. Transfusion Med Rev 1999; 13: 95-105.
24. Poon MC. Factor VIIa. In: Michelson AD, eds. Platelets. New York: Elsevier Science, 2002: 867-73.
25. Poon MC, Demers C, Jobin F, Wu JW. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood 1999; 94: 3951-3.
26. Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, Kutti J, Mellqvist UH, Johansson JE, Glazer S, Hedner U. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 1996; 26 (Suppl. 1): 159-64.
27. Friederich PW, Henny CP, Messelink EJ, Geerdink MG, Keller T, Kurth K-H, Büller HR, Levi M, Effect of recombinant activated factor VII. on perioperative blood loss in patients undergoing retropubic prostatectomy. A double-blind placebo-controlled randomized trial. Lancet; 2003; 361: 201-5.
28. Tranholm M, Røjkjaer R, Pyke C, Kristensen AT, Klitgaard B, Lollike K, Blajchman MA. Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits. Thromb Res 2003; in press.
29. Blajchman MA, Bordin JO, Bardossy J, Heddle NM. The contribution of the hematocrit to thrombocytopenic bleeding in experimental animals. Br J Haematol 1994; 86: 347-50.
30. Ho C-H. The hemostatic effect of packed red cell transfusion in patients with anemia. Transfusion 1998; 38: 1011-4.
31. Blajchman MA. Plateletsubstitutes. Vox Sang 2000; 38 (Suppl. 2): 183-6.